Peptides, owing to their potential for heightened receptor selectivity, binding affinity, and tumor retention, may outstrip other FAP inhibitors in the realms of diagnostic and therapeutic efficacy [234,235,236,237,238,239]. Here, FAP is linked to neoplasm.